ALLO-501,allo-501A
allogene therapeutics
['lymphoma', 'allogene therap', '$allo']
allogene therapeutics presents updated allo-501/501a phase 1 data in large b cell lymphoma at the american society of clinical oncology (asco) annual meeting - health stocks hub $allo 
Real-Time News, Market Data, Insider Trades, and Stock Quotes for Biotech, Pharma, Medical, and Healthcare Stocks @ https://t.co/Oqp6BRBKy2